Chlamydia trachomatis targets mitochondrial dynamics to promote intracellular survival and proliferation.


Journal

Cellular microbiology
ISSN: 1462-5822
Titre abrégé: Cell Microbiol
Pays: India
ID NLM: 100883691

Informations de publication

Date de publication:
01 2019
Historique:
received: 06 06 2018
revised: 18 09 2018
accepted: 04 10 2018
pubmed: 13 10 2018
medline: 7 2 2020
entrez: 13 10 2018
Statut: ppublish

Résumé

Chlamydia trachomatis is an obligate intracellular bacterium that scavenges host metabolic products for its replication. Mitochondria are the power plants of eukaryotic cells and provide most of the cellular ATP via oxidative phosphorylation. Several intracellular pathogens target mitochondria as part of their obligatory cellular reprogramming. This study was designed to analyse the mitochondrial morphological changes in response to C. trachomatis infection in HeLa cells. Mitochondrial elongation and fragmentation were found at the early stages and late stages of C. trachomatis infection, respectively. C. trachomatis infection-induced mitochondrial elongation was associated with the increase of mitochondrial respiratory activity, ATP production, and intracellular growth of C. trachomatis. Silencing mitochondrial fusion mediator proteins abrogated the C. trachomatis infection-induced elevation in the oxygen consumption rate and attenuated chlamydial proliferation. Mechanistically, C. trachomatis induced the elevation of intracellular cAMP at the early phase of infection, followed by the phosphorylation of fission-inactive serine residue 637 (S637) of Drp1, resulting in mitochondrial elongation. Accordingly, treatment with adenylate cyclase inhibitor diminished mitochondrial elongation and bacterial growth in infected cells. Collectively, these results strongly indicate that C. trachomatis promotes its intracellular growth by targeting mitochondrial dynamics to regulate ATP synthesis via inhibition of the fission mediator Drp1.

Identifiants

pubmed: 30311994
doi: 10.1111/cmi.12962
doi:

Substances chimiques

Adenosine Triphosphate 8L70Q75FXE

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e12962

Informations de copyright

© 2018 John Wiley & Sons Ltd.

Auteurs

Yusuke Kurihara (Y)

Department of Microbiology and Immunology, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.

Ryota Itoh (R)

Department of Microbiology and Immunology, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.

Akinori Shimizu (A)

Department of Microbiology and Immunology, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.

Nirwana Fitriani Walenna (NF)

Department of Microbiology and Immunology, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.
Faculty of Medicine, Hasanuddin University, Makassar, Indonesia.

Bin Chou (B)

Department of Microbiology and Immunology, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.

Kazunari Ishii (K)

Department of Microbiology and Immunology, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.

Toshinori Soejima (T)

Department of Microbiology and Immunology, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.

Aya Fujikane (A)

General Medicine, Fukuoka University Hospital, Fukuoka, Japan.

Kenji Hiromatsu (K)

Department of Microbiology and Immunology, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH